Veeren Chauhan is a Nottingham Research Fellow in Whole Organism Analytics in the Advanced Materials & Healthcare Technologies (AMHT) division at the School of Pharmacy, University of Nottingham. He conducts multidisciplinary research at the interface of analytical, biological and medical sciences. This research endeavours to produce analytical and biologically inspired therapeutic solutions for global challenges that will cure, prevent and alleviate the symptoms of disease.
Veeren is a General Pharmaceutical Council (GPhC) registered Pharmacist, having completed his undergraduate education at the University of Manchester (MPharm) and training at University Hospitals Coventry & Warwickshire. He has held lead pharmacist roles in the academic, industrial and commercial settings working as part of multidisciplinary healthcare teams.
He undertook his postgraduate education (PhD) at the School of Pharmacy, University of Nottingham and GlaxoSmithKline (GSK). Veeren's PhD focused on the innovation and application of fluorescent nanosensors, to elucidate fundamental biochemical processes in model systems, such as the nematodes Caenorhabditis elegans & Pristionchus pacificus, human mesenchymal stem cells (hMSCs), Saccharomyces cerevisiae and Microelectromechanical systems (MEMS) devices.
As a postdoctoral research fellow, Veeren has partnered and attracted funding for an InnovateUK Knowledge Transfer Partnership with TBG Solutions Ltd. Here, he applied his diagnostic & nano-formulation expertise to conceptualise and manufacture gold-aptamer based nano-constructs, capable of transducing chemical signals into an electronic output in the presence of specific viral nucleic acid. More recently, Veeren has worked as part of the EPSRC Future Targeted Healthcare Manufacturing Hub, aiming to develop transformative solutions for healthcare precision in the biotherapeutics sector. He has developed methods for the continuous manufacture of novel polymeric and protein based nano and microparticles for the controlled and targeted delivery of biologic medicine.
Veeren has also applied his interest of early diagnosis of disease to the determine the physicochemical fingerprint of Necator americanus, or 'American Murderer,' a parasitic hookworm that infects ~10% of the world's population. Atomic Force Microscopy (AFM) and Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) were used to uncover the surface topographical features and chemical identity of the infective larval stage of N. americanus to provide key insights into its infection mechanism. It is anticipated, these findings will lead to the development of treatments, such as vaccines, not only for N. americanus but other globally important infectious diseases.
For a detailed up-to-date history of Veeren's experience, education and accomplishments please see his personal website.
Veeren has taken a collaborative and multidisciplinary approach to academic and industrial research, which has enabled him to develop excellent leadership, teamwork and communication skills on a broad range of scientific disciplines. This has enabled him to establish strong long-term collaborative partnerships with national and international institutes that have produced impactful research. He endeavours to continue to develop these skills to lead projects at the forefront of medical and pharmaceutical research.
For an up-to-date record of Veeren's publications please see Google Scholar.